- A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Alzheimer’s Disease
- Allopregnanolone Regenerative Therapeutic for Mild Alzheimer’s Disease
- Alzheimer’s Disease Genetics Study
- Expanded Access With Trappsol(R) Cyclo (TM) for an Individual Patient With Late Onset Alzheimer’s Disease
- Genetic Studies in Familial Dementia
- Knowledge, Attitudes and Beliefs About AD Among Latinos in NYC
- Korean Brain Aging Study for Early Diagnosis and Prediction of Alzheimer’s disease2 (KBASE2)
- Late Onset Alzheimer’s Disease
- Measuring Brain Amyloid Plaque Load in Older Adults Using BAY 94-9172
- Response to Donepezil, Drug Plasma Concentration and the CYP2D6 and APOE Genetic Polymorphisms
- S-Equol in Alzheimer’s Disease 2 Trial
- Study of APH-1105 in Patients With Mild to Moderate Alzheimer’s Disease
Clinical Trials
- Ameparomo Capsules 250 mg Drug Use Investigation
- Anaemetro I.V. Infusion 500mg Drug Use Investigation
- Auranofin for Giardia Protozoa
- Auranofin PK Following Oral Dose Administration
- Study of Nitazoxanide in the Treatment of Amebiasis in Adults and Adolescents
- Study of Nitazoxanide in the Treatment of Amebiasis in Children
- Amelogenesis Imperfecta
- Clinical Performance of Composites in Patients With Amelogenesis Imperfecta
- Colorimetric, Ultra-structural and Elemental Comparison of Dental Enamel Defects
- Dental Age Estimation by Different Methods in Patients With Amelogenesis Imperfecta
- E. Max Laminate Veneers With and Without Using Galla Chinnesis as Natural Cross Linking and Remineralizing Agent
- A Pilot Study of RNS60 in Amyotrophic Lateral Sclerosis (ALS)
- Adenosine 2A Receptor Antagonism and AIH in ALS
- Assessment of Voluntary and Reflex Cough in Patients With ALS
- Coping Effectiveness Training for ALS
- ECoG Direct Brain Interface for Individuals With Upper Limb Paralysis
- Efficacy and Safety Extension Study of Oral Edaravone Administered in Subjects With ALS
- Efficacy and Safety Study of Oral Edaravone Administered in Subjects With ALS
- Exposure to Neurotoxins as Risk Factors for ALS
- Neuromuscular Ultrasound in ALS
- Non-invasive Brain Stimulation for the Treatment of Depression Symptoms in ALS
- Remote Pulmonary Function Testing and Nurse Coaching in ALS
- Safety Study of Oral Edaravone Administered in Subjects With ALS
- Trial of Oxaloacetate in ALS
- A Message Framing Intervention for Increasing Parental Acceptance of Human Papillomavirus Vaccination
- A Phase I/II Evaluation of ADXS11-001, Mitomycin, 5-fluorouracil (5-FU) and IMRT for Anal Cancer
- A Prospective, Open-Label, Multi-center Comparison of Lymphoseek Identified Lymph Nodes and Clinically Identified Lymph Nodes of Subjects With Known Cancer of the Anus
- A Study of mDCF in Combination or Not With Atezolizumab in Advanced Squamous Cell Anal Carcinoma
- Anal Cancer Radiotherapy Study
- Anal Cancer Screening Study
- Anal HPV Tests in Screening for Cell Changes in the Anus in Patients With HIV
- Anal Injury Screening for High Risk HPV
- Anal Sphincter Prosthesis in Treating Patients Who Are Undergoing Surgery for Anal or Rectal Cancer
- ANCA II – Quality of Life and Functional Outcome in Patients With Anal Cancer
- ART: Anal Squamous Cell Carcinoma: Investigation of Functional Imaging During chemoRadioTherapy
- Assessment of Health Related Quality of Life in Patients Treated for Rectal Cancer
- Assessment of Patients’ Quality of Sexual Life After Anal Cancer Treatment
- Assessment of Symptom-Related Cytokines in Lung and Gastrointestinal (GI) Cancer Patients
- Avastin/[18-F]-5-fluorouracil PET/CT Imaging Feasibility Project
- Bone-sparing Chemoradiotherapy for Anal Cancer – DACG-II
- Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
- Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal Cancer
- Chemoradiotherapy Combined With or Without PD-1 Blockade in Anal Canal Squamous Carcinoma Patients
- Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
- Circulating Biomarkers in Patients With Anal Cancer Treated With Induction Chemotherapy
- Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
- Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies
- Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal Cancer
- Comparing Two Types of Swabs in Collecting Cell Samples for Anal Pap Tests and Human Papillomavirus Tests in Men Who Have Sex With Men
- CRTE7A2-01 TCR-T Cell for HPV-16 Positive Advanced Cervical, Anal, or Head and Neck Cancers
- Detecting HPV DNA in Anal and Cervical Cancers
- Drainage Seton With Flap Versus EAS Preserving Seton in Treatment of Transsphincteric Anal Fistula
- Early Rectal Cancer: Endoscopic Submucosal Dissection or Transanal Endoscopic Microsurgery?
- Function Following Laser for Anal Intraepithelial Neoplasia (FLAN)
- Functional Outcomes Following Anal Cancer Treatment
- High-Resolution Anoscopy Perceived Discomfort Study
- HPV-SAVE: 9-Valent HPV Vaccine for High-Grade Anal Dysplasia
- Hybrid Capture 2 Human Papiloma Virus (HPV) High-Risk Anal DNA Test
- Hyperthermia Enhanced Re-irradiation of Loco-regional Recurrent Tumors
- Identification of Predictive Factors for Physiological Hypermetabolism of the Anal Canal in 18F-FDG PET / CT
- Image Fusion PET, CT and 3D-ultrasound Examinations
- Individual Following in Anal Cancer With PET/CT
- Infrared Coagulation in Preventing Anal Cancer in Patients With HIV Who Have Anal Neoplasia
- Infrared Coagulator Ablation or Observation in Preventing Anal Cancer in HIV-Positive Patients With Anal Neoplasia
- Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer
- Intrafractional Vaginal Dilation in Anal Cancer Patients Undergoing Pelvic Radiotherapy
- M7824 in Subjects With HPV Associated Malignancies
- Molecular Genetic and Pathological Studies of Anal Tumors
- Multimodal Monitoring of Radiotherapy Response in Squamous Cell Cancer
- Neoadjuvant PD-1 Blockade Combined With Chemotherapy Followed by Concurrent Immunoradiotherapy for Locally Advanced Anal Canal Squamous Carcinoma Patients
- Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer
- Pembrolizumab in Refractory Metastatic Anal Cancer
- Pencil Beam Proton Therapy for Recurrences in Anal Cancer Patients Previously Treated With Radiotherapy (DACG 5)
- Phase 2 Study of ADXS11-001 in Subjects With Carcinoma of the Anorectal Canal
- Pilot Study to Determine the Safety and Efficacy of Gardasil Against the Human Papilloma Virus (HPV) in HIV-infected Men
- Predictive Value of FMISO-PET, FDG-PET-CT, DWI-MRI and DCE-MRI Scans for Patients With Anal Cancer Receiving Radiotherapy +/- Chemotherapy
- Prospective Cohort on Quality of Sexual Life Among Men Who Have Sex With Men Treated for Anal Cancer With Concurrent Chemotherapy and Intensity-modulated Radiotherapy
- Prospective Observational Trial to Evaluate Quality of Life After Definitive Chemoradiation in Patients With Anal Cancer (LANACARE)
- QOL & Functional Outcomes After Combined Modality Tx for Anal CA: Comparison of Conventional vs IMRT
- Quality of Life in Patients With Anal Cancer
- Radiation Dosimetry Study Comparing 2 Different Patient Setups in Anal/Rectal Cancer Patients
- Radiation Therapy Plus Fluorouracil With or Without Additional Chemotherapy in Treating Patients With Primary Anal Cancer
- Radiation Therapy, Cisplatin, Fluorouracil, and Cetuximab in Treating Patients With Locally Advanced Anal Cancer
- Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer
- Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma. A Multicenter, Randomized, Phase II Trial of the German Anal Cancer Study Group
- Re-optimization Based Online Adaptive Radiotherapy of Anal Cancer
- RTX-321 Monotherapy in Patients With HPV 16+ Tumors
- Screening for HIV-Associated Anal Cancer
- SGN-00101 in Preventing Anal Cancer in Patients With HIV Who Have Anal Neoplasia
- Shared Decision Making With Anal Cancer Patients on Radiation Dose
- Study of IMRT Radiotherapy Concurrent Chemothrerapy for Anal Cancer
- The HPV-SAVE Study Team: HPV Screening and Vaccine Evaluation in Men Who Have Sex With Men
- The Prevent Anal Cancer Self-Swab Study
- Topical MTS-01 for Dermatitis During Radiation and Chemotherapy for Anal Cancer
- Trial To Test Safety And Efficacy Of Vaccination For Incurable HPV 16-Related Oropharyngeal, Cervical And Anal Cancer
- A Dose-Escalation/ Dose-Expansion Study of SY-3505 in Patients With ALK-positive Non-small Cell Lung Cancer
- A Phase II Study to Evaluate the Efficacy and Safety of Oral Ceritinib in Patients With ALK-positive NSCLC Metastatic to the Brain and/or to Leptomeninges
- A Study Comparing Ensatinib Versus Platinum-Based Chemotherapy as Adjuvant Treatment for Stage II-IIIA ALK -Positive Non-Small Cell Lung Cancer
- A Study to Evaluate and Compare the Efficacy and Safety of Alectinib Versus Crizotinib and to Evaluate the Pharmacokinetics of Alectinib in Asian Participants With Treatment-Naive Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small Cell Lung Cancer (NSCLC)
- Adjuvant Therapy of Ensartinib in Stage IB-IIIA ALK-positive Non-small Cell Lung Cancer
- Alkotinib Capsule in Patients With ALK-positive Non-small Cell Lung Cancer Previously Treated With Crizotinib
- An Observational Research Of Crizotinib’s Hepatic Toxicity In Non-small Cell Lung Cancer Patients
- Ceritinib + Trametinib in Patients With Advanced ALK-Positive Non-Small Cell Lung Cancer (NSCLC)
- Ceritinib in Combination With Stereotactic Ablative Radiation Metastatic Lung Adenocarcinoma
- eXalt3: Study Comparing X-396 (Ensartinib) to Crizotinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients
- Immune and Genomic Markers in ALK+ NSCLC
- LDK378 in Patients With ALK Positive NSCLC Previously Treated With Alectinib.
- Lorlatinib in ALK Inhibitor Treated Unresectable Advanced/Recurrent ALK-Positive Non Small Cell Lung Cancer Patients in India
- Patient-centered, Optimal Integration of Survivorship and Palliative Care
- Study Comparing WX-0593 to Crizotinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients
- Study of Safety and Efficacy of LEE011 and Ceritinib in Patients With ALK-positive Non-small Cell Lung Cancer.
- Study of Safety, Efficacy and Pharmacokinetics of CT-707 in Patients With ALK-positive Non-small Cell Lung Cancer
- Study to Evaluate Clinical Real World Outcomes of Lorlatinib After Alectinib in ALK-Positive NSCLC Japanese Patients
- Study to Evaluate Safety, Efficacy, Pharmacokinetics And Pharmacodynamics Of Avelumab In Combination With Either Crizotinib Or PF-06463922 In Patients With NSCLC. (Javelin Lung 101)
- X-396 Capsule in Patients With ALK-positive Non-small Cell Lung Cancer Previously Treated With Crizotinib
- 1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia
- 24 Week Clinical Trial to Evaluate Safety and Effectiveness of a Hair Growth System to Treat Male and Female Baldness
- A Clinical Trial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of IVL3001
- A Novel Approach to Treating Androgenetic Alopecia in Females With Low Level Laser Therapy
- A Phase 2 Study to Evaluate the Safety and Efficacy of CB-03-01 Solution, a Comparator Solution and Vehicle Solution in Males With Androgenetic Alopecia
- A Phase 2a Trial of FOL-005 Topical Formulations to Investigate Hair Growth Potential and Safety in Healthy Male Volunteers
- A Randomized, Double-blind Clinical Trial to Evaluate the Safety and Efficacy of the X5 HairLaser for the Treatment of Androgenetic Alopecia in Males
- A Study Evaluating the Efficacy and Safety of SM04554 Topical Solution in Male Subjects With Androgenetic Alopecia
- A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Female Subjects With Hair Loss
- A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Male Subjects With Hair Loss
- A Study in Male and Female Subjects With Androgenetic Alopecia Treated With ATI-50002 Topical Solution
- A Study of SM04554 Applied Topically to the Scalp of Male Subjects With Androgenetic Alopecia Analyzed by Biopsy of the Scalp Prior To and Post Dosing
- A Study of the Safety, Tolerability, and Efficacy of Topical SM04554 Solution in Male Subjects With Androgenetic Alopecia (AGA)
- A Study to Determine the Safety and Efficacy of Autologous Human Platelet Lysate for Treatment of Androgenetic Alopecia
- A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss
- A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002012)
- A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002013)
- A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002899)
- A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004512)
- A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004541)
- A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004669)
- A Study to Evaluate and Compare Injections of Autologous Dermal Cells Into the Balding Scalp of Subjects With Hair Loss
- A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0006931)
- A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004542)
- A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0005995)
- A Study to Evaluate the Effectiveness and Safety of 5 Percent Minoxidil Foam in the Treatment of Male Pattern Hair Loss
- A Study to Evaluate the Efficacy and Safety of AD-208
- A Study to Evaluate the Superiority, Efficacy and Tolerability of Combination Pantovigar With 2% Minoxidil vs 2% Minoxidil in Women With Female Pattern Hair Loss
- Activated PRP for Treatment of Androgenetic Alopecia
- Adipose Derived Stem Cells Versus Platelet Rich Plasma on Follicular Unit Extraction
- Adipose-derived SVF for Treatment of Alopecia
- Androgenetic Alopecia and the JAK-STAT Pathway
- Androgenetic Alopecia Treatment Using Varin and Cannabidiol Rich Topical Hemp Oil: A Case Series
- Anti-Androgen Treatment for COVID-19
- Association of Androgenetic Alopecia and Severity of Coronavirus Disease 2019 (COVID-19).
- Clinical Trial in Females for Female Pattern Hair Loss
- Clinical Trial to Explore the Efficacy and Safety of DA-4001 After Topical Application
- Cold Plasma to Treat Hair Loss
- Comparing Different Platelet Rich Plasma (PRP) Treatment Regimens for Management of Androgenic Alopecia
- Comparison Between Efficacy of Topical Sildenafil 2% and Topical Minoxidil 5% in Treatment of Androgenic Alopecia
- Computer-Assisted Hair Implantation Using ARTAS System VS Manual Implantation Technique Hair Restoration Study
- Computer-Assisted Versus Manual Hair Harvest Comparative Study
- Dose-Ranging Efficacy Study of Topical NEOSH101 to Treat Male Pattern Hair Loss
- Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia
- Effect of Pumpkin Seed Oil on Hair Growth in Men With Androgenetic Alopecia
- Effect of the Composition From Fish on Promoting Hair Growth
- Effectiveness and Safety of Minoxidil Foam Versus Placebo Foam for Androgenetic Alopecia
- Effects of Finasteride on Serum Prostate-Specific Antigen (0906-111)
- Efficacy and Safety of Finlândia Hair Lotion Association on Androgenetic Alopecia
- Efficacy and Safety of Platelet Rich Plasma in Androgenetic Alopecia
- Efficacy and Safety Study to Compare Two Minoxidil Formulations on Women With Androgenetic Alopecia
- Efficacy of Nutrition Supplement for Treatment of Men With Hair Loss
- Efficacy of Platelet-Rich Plasma Therapy for Androgenetic Alopecia: A Systematic Review and Meta-analysis
- Efficacy of Platelet-Rich Plasma Versus Mesotherapy in Androgenetic Alopecia: A Retrospective Study
- Efficacy Study of a Cosmetic Lotion in the Treatment of Androgenetic Alopecia in Males and Females
- Efficacy Study of Minoxidil Lotion Versus Combined Minoxidil and Finasteride Lotion to Treat Male Pattern Hair Loss
- Efficacy Study of Topical NEOSH101 to Treat Male Pattern Hair Loss
- Evaluate the Clinical Effectiveness of RegenKit Platelet-rich Plasma (PRP) in Androgenetic Alopecia Treatment
- Evaluating the Efficacy of Microneedling in the Treatment of Androgenetic Alopecia
- Evaluating the Efficacy of Platelet-rich Plasma Therapy in the Treatment of Androgenic Alopecia
- Evaluating the Topical Herbal Solution on the Treatment of Male Pattern Hair Loss and Comparison With Minoxidil 5%
- Follicular Revival in Androgenic Alopecia: Evaluating Use of Micro-needling
- Fractional Laser Versus Radiofrequency in Androgenetic Alopecia
- Hair Growth Efficacy and Safety of NGF-574H in Adult With Androgenic Alopecia
- HairDx Analytical Validation Study
- Hydraderm for Androgenic Alopecia
- Laser Assisted Delivery of Minoxidil in Androgenetic Alopecia
- Local Pharmacokinetics and Tolerability of Bimatoprost Applied to the Scalp of Male Patients With Androgenetic Alopecia
- Low Level Light Device as a Primary Therapy for Androgenetic Alopecia
- Microarray Analysis of Scalp Biopsies After Minoxidil Treatment
- Minoxidil Dose Response Study in Females Identified Through IVD Testing as Non-Responders to 5% Topical Minoxidil
- Minoxidil Response Testing in Males With Androgenetic Alopecia
- Modulated Light Therapy in Participants With Pattern Hair Loss
- N-Acetyl-Cysteine for Treatment of AGA in Men
- Nanofat Grafting for Treatment of Androgenetic Alopecia
- Optimizing Parameters for Long-pulsed Nd:YAG Laser for Reducing Hair Shaft Diameter
- PAI-1 Expression in Non-scarring Hair Loss
- Pharmacokinetics/ Pharmacodynamics and Safety of DA-4001 in Healthy Male Subjects With Androgenic Alopecia
- Photosensitization Study in Androgenetic Alopecia
- Plasma Rich in Growth Factors (PRGF-Endoret)in the Treatment of Androgenetic Alopecia
- Point-of-Care Adipose-derived Cells for Hair Growth
- Safety and Efficacy of Hair Stimulating Complex (HSC) on Hair Growth in Males With Androgenetic Alopecia
- Safety, Tolerability and Pharmacokinetics of KX826 in Healthy Male Subjects With Androgenetic Alopecia Following Topical Single Ascending Dose Administration
- Sham LaserCap vs. LaserCap SD vs. LaserCap HD+
- Split Wound Comparison of Trichophytic Closure Techniques for Donor Site in Hair Transplantation
- Study in Subjects to Evaluate the Safety, Tolerability and Pharmacokinetics of GT20029
- Study to Assess Efficacy of Platelet-Rich Plasma in Androgenetic Alopecia
- Study To Determine Safety & Efficacy Of Autologous Human Platelet Lysate in Androgenetic Alopecia After Hair Transplant
- The Effect of Allogeneic Human Adipose Derived Stem Cell Component Extract on Androgenic Alopecia
- The Effect of Platelet Rich Plasma on Non-scarring Alopecia
- The Effect of Platelet-rich Plasma in Subjects With Androgenetic Alopecia
- The Efficacy and Safety of Topical Valproic Acid in Preventing Hair Loss
- the Safety, Tolerability and PK of KX-826 in Healthy Males With Alopecia Following Topical Multiple Dose Ascending
- The Use of 5mg Finasteride Versus 200mg Spironolactone and Topical 5% Minoxidil in Treating Postmenopausal Female Androgenetic Alopecia
- The Utility of Platelet Rich Plasma in Hair Loss
- Thulium Laser and KeraFactor for the Treatment of Androgenetic Alopecia
- Thulium Laser and Topical Platelet Rich Plasma (PRP) vs. PRP Injection for the Treatment of Male Androgenetic Alopecia
- To Evaluate the Pharmacokinetics and Safety of AD-208
- To Evaluate the Safety, Tolerability and Efficacy in Male and Female With AGA Treated With HMI-115 Over a 24-week Treatment Period
- To Investigate Efficacy of FOL-005 on Hair Growth on Scalp Skin
- Topical Bimatoprost Effect on Androgen Dependent Hair Follicles
- Topical Cetirizine 1% vs Minoxidil 5% Gel in Treatment of Androgenetic Alopecia
- Topical Cetirizine in Androgenetic Alopecia in Females
- Treatment of Androgenetic Alopecia in Females, 12 Beam
- Treatment of Androgenetic Alopecia in Females, 9 Beam
- Treatment of Androgenetic Alopecia in Males
- Treatment of Androgenetic Alopecia in Males and Females
- Treatment of Androgenetic Alopecia in Males With Theradome™ LH80 PRO
- Treatment of Androgenic Alopecia in Males
- Use of Botulinum Toxin in the Treatment of Androgenic Alopecia
- Aneuploidies and Different Stimulation Protocols
- Aneuploidy Rates in Advanced Maternal Age Patients Supplemented With Coenzyme Q10 (CoQ10) Versus Those That Are Not: a Pilot Study
- Aneuploidy Rates of in Vitro Matured Oocytes
- Assessment of Implantation Potential of Embryos by Time-lapse Technology
- Clinical Value of Mosaicism Diagnosis on the Trophectoderm Biopsies
- Does an Educational Video for Aneuploidy Screening Improve Informed Choice Among Pregnant Women?
- Exploring Single Step Culture Medium Refreshment Effect on Embryo Ploidy Rate
- Multi-center Study to Validate niPGT-A
- Noninvasive Chromosomal Screening for Embryo Selection Trial
- Nuclear Magnetic Resonance for Embryo Ploidy Selection
- Polar Body Biopsy for Preimplantation Genetic Screening
- Pregnancy and Developmental Outcomes After Transfer of Reportedly Aneuploid or Mosaic Embryos
- Prenatal Computer-Aided Genetics Education Module
- RCT Study to Validate niPGT-A Clinical Benefit.
- Single Embryo TrAnsfeR of Euploid Embryo
- Use of a Novel Computerized Decision Aid for Prenatal Aneuploidy Screening
- Use of Videos to Improve Patient Knowledge on Prenatal Genetics
- A Study in Adults and Adolescents With Angelman Syndrome
- A Study of the Safety and Tolerability of GTX-102 in Children With Angelman Syndrome
- A Study To Assess Distribution Of RO7248824 In The Central Nervous System Following Single Intrathecal Doses Of [89zr] Labeled RO7248824 In Healthy Male Participants
- A Study To Investigate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of RO7248824 In Participants With Angelman Syndrome
- A Trial of Levodopa in Angelman Syndrome
- An Open-Label Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of OV101 in Individuals With Angelman Syndrome
- Angelman Syndrome (AS) Biomarker Study
- Angelman Syndrome Italian Registry
- Angelman Syndrome Natural History Study
- Angelman Syndrome Natural History Study- FAST UK
- Characterization of Angelman Syndrome
- HALOS: A Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Multiple Ascending Doses of ION582 in Participants With Angelman Syndrome
- Minocycline in the Treatment of Angelman Syndrome
- Nutritional Formulation for Angelman Syndrome
- Study on Tolerability of Levodopa/Carbidopa in Children With Angelman Syndrome
- Study to Evaluate the Efficacy and Safety of Minocycline in Angelman Syndrome
- The Global Angelman Syndrome Registry